FindTrial
Sign In

Impact on a novel microfluidic chip rapid detection method on the appropriateness of antibiotics for patients with severe pneumonia

Impact on a LAMP microfluidic chip rapid detection method on the appropriateness of antibiotics for patients with severe pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030227
Enrollment
Unknown
Registered
2020-02-25
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia

Interventions

Conventional group:Culture
Experimental group:novel LAMP microchip detection method

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged beyond 18 years old; 2. Suspected or diagnosed with severe pneumonia within 24 hours on ICU admission; 3. Patients who are suspected of VAP within 24 hours; 4. Expected stay more than 72 hours from inclusion; 5. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have definitive etiology diagnosis; 2. There are severe infection in other sites which will impact the antibiotic use; 3. Patients who are already included within the 7 day follow-up period; 4. Patients who choose palliative care; 5. Patients who request withdraw from the study; 6. Women who are pregnant or breast feeding.

Design outcomes

Primary

MeasureTime frame
the appropriateness of antibiotics;—

Secondary

MeasureTime frame
The comsumption of antibiotics;—

Contacts

Public ContactKang Yan

West China Hospital, Sichuan University

kangyan_hx@163.com+86 18980601566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026